These findings suggest LRRK2’s role in mtDNA damage in both iPD and LRRK2 PD, but to date, research comparing various facets of mitochondrial dysfunction in LRRK2 PD-manifesting and non-manifesting carriers is limited. The gene discussed is LRRK2; the disease is Parkinson disease.